矽肺的基本病理变化为肺组织由炎性变化到慢性弥漫性纤维化的过程,以及导致“肺性心脏病”的病理改变。因此在这次矽肺临床中也是针对这一观念而开展治疗的,即在中西医综合疗法中以“辨证论治”重用“活血化淤”药物,来消除矽肺患者“气滞血淤”的症候。在治疗过程中除了对一般自觉症状、体征、血、尿矽及X线观察外,同 The basic pathological changes in silicosis are changes in the lung tissue from inflammatory to chronic diffuse fibrosis, as well as the pathological changes leading to “pulmonary heart disease.” Therefore, in this silicosis clinical treatment is also directed at this concept, that is, in the integrated traditional Chinese and Western medicine in the “syndrome differentiation” reuse “blood stasis” drugs to eliminate silicosis patients “qi stagnation and blood stasis” symptoms. In the course of treatment in addition to the general symptoms, signs, blood, urine and silicon X-ray observation, the same